Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux disease

OBJECTIVE: To evaluate the safety and pharmacokinetic profile of dexlansoprazole modified-release (MR) capsules in pediatric patients with symptomatic gastroesophageal reflux disease (GERD). METHODS: This Phase I, open-label study enrolled male and female patients (1 to 11 years of age) with GERD. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Kukulka, Michael, Nudurupati, Sai, Perez, Maria Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266249/
https://www.ncbi.nlm.nih.gov/pubmed/25525378
http://dx.doi.org/10.2147/CEG.S67672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266249/
https://www.ncbi.nlm.nih.gov/pubmed/25525378
http://dx.doi.org/10.2147/CEG.S67672

Ejemplares similares